We are live on ! Find out more
BLU

BELLUS Health Inc.
BLU

Delisted

BLU was delisted on the 28th of June, 2023.

Back to rankings

40 hedge funds and large institutions have $170M invested in BELLUS Health Inc. in 2019 Q3 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+40
Holders Change %
–
% of All Funds
0.88%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
40
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$49.6M
2
RI
RTW Investments
New York
+$29.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$28.6M
4
First Manhattan
First Manhattan
New York
+$17.9M
5
PC
Polar Capital
United Kingdom
+$14.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$45.1M +$49.6M +7,025,832 New
RI
2
RTW Investments
New York
$26.9M +$29.5M +4,178,156 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$25.9M +$28.6M +4,054,377 New
First Manhattan
4
First Manhattan
New York
$16.2M +$17.9M +2,538,326 New
PC
5
Polar Capital
United Kingdom
$14M +$14.9M +2,113,673 New
BC
6
Boxer Capital
California
$11.3M +$12.5M +1,775,000 New
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$8.31M +$9.17M +1,300,000 New
Citadel Advisors
8
Citadel Advisors
Florida
$5.87M +$6.47M +916,636 New
ACP
9
Acuta Capital Partners
California
$5.02M +$5.54M +785,000 New
MP
10
Mangrove Partners
Connecticut
$2M +$2.21M +313,849 New
DCM
11
Driehaus Capital Management
Illinois
$1.8M +$1.99M +282,000 New
DMK
12
David M. Knott
$1.56M +$1.71M +242,611 New
Artisan Partners
13
Artisan Partners
Wisconsin
$1.12M +$1.23M +175,000 New
SSA
14
Schonfeld Strategic Advisors
New York
$1.09M +$1.2M +169,952 New
Goldman Sachs
15
Goldman Sachs
New York
$683K +$754K +106,924 New
Alyeska Investment Group
16
Alyeska Investment Group
Illinois
$449K +$496K +70,248 New
Millennium Management
17
Millennium Management
New York
$424K +$468K +66,400 New
JP Morgan Chase
18
JP Morgan Chase
New York
$400K +$442K +62,594 New
Morgan Stanley
19
Morgan Stanley
New York
$367K +$405K +57,458 New
Point72 Asset Management
20
Point72 Asset Management
Connecticut
$257K +$284K +40,294 New
WMSA
21
Weiss Multi-Strategy Advisers
New York
$256K +$282K +40,000 New
Renaissance Technologies
22
Renaissance Technologies
New York
$247K +$271K +38,438 New
MIM
23
Monashee Investment Management
Massachusetts
$192K +$212K +30,000 New
FDCDDQ
24
Federation des caisses Desjardins du Quebec
Quebec, Canada
$116K +$131K +18,504 New
TAM
25
Tiverton Asset Management
Delaware
$116K +$128K +18,113 New
1
2

BLU Hedge Fund Activity: Q3 2019 in Review

40 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q3 2019, worth a combined $170M.

Buyers outnumbered sellers: 40 funds opened new BLU positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $49.6M.

  • 40 institutional investors held BELLUS Health Inc. (BLU) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $170M of BELLUS Health Inc. stock for Q3 2019.
  • 40 funds opened new BELLUS Health Inc. positions in Q3 2019 and 0 closed out, a net change of +40 holders.
  • The largest BELLUS Health Inc. buyer in Q3 2019 was OrbiMed, an estimated $49.6M added.

Based on aggregated 13F filings for Q3 2019.